Pediatric critical care remains a pivotal frontier in modern medicine, confronting unique challenges shaped by the dynamic physiology and developmental ...

"The program has earned multiple U.S. Food and Drug Administration accelerated approval pathway designations, including RMAT, Fast Track, Orphan Drug, and Rare Pediatric Disease ... at both the ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts caution that more research is needed. Gavin Nielsen was 2 years old when ...

Gavin Nielsen, who was 2 years old when he was diagnosed with a rare brain cancer, met Dr. Nicholas Vitanza who is part of a growing group of researchers exploring CAR-T therapy. The treatment ...

Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh developed a new way to profile brain cancers in children ...

When RIT student Miriam Rigas sought volunteer experience as a high school junior, she found a calling and a career path working with children touched by cancer. The physician assistant (PA) major ...

Sebastien Beauzile became the first person in NY to be made symptom-free after undergoing a new type of gene therapy.

Northvolt AB today announced that it has filed for bankruptcy in Sweden. It says Northvolt North America is solvent, but what will happen to its massive EV battery plant project in Canada?

These findings emphasize the potential of a biomarker-driven, multi-faceted approach to managing pediatric POTS. Individualized treatment strategies are the future of managing pediatric POTS.